Key data
Open—
From 52W high—
Volume—
Market cap—
P/E (TTM)—
P/S (TTM)—
Div yield—
Key data
Open
—
From 52W high
—
Volume
—
Market cap
—
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
P/E (TTM)
—
RSI (14)
—
MomentumView details →
1D Return
—
YTD Return
—
Latest newsMore news →
Ono Pharmaceutical announced it obtained manufacturing and marketing approval from the Ministry of Health, Labour and Welfare for its anti-epileptic drug Cenobamate for the treatment of partial-onset seizures.4d agoAitia and Ono Pharmaceutical announced a collaboration to use Aitia's causal AI-based Gemini Digital Twin Platform to discover novel drug targets in neurological diseases.19d ago